Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    July 2017
  1. ZHU W, Jarman KE, Lokman NA, Neubauer HA, et al
    CIB2 negatively regulates oncogenic signaling in ovarian cancer via sphingosine kinase 1.
    Cancer Res. 2017 Jul 20. pii: canres.0025.2017.
    PubMed     Text format     Abstract available


    May 2017

  2. Correction: Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.
    Cancer Res. 2017;77:2770.
    PubMed     Text format    


    April 2017
  3. SANS M, Gharpure KM, Tibshirani R, Zhang J, et al
    Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.
    Cancer Res. 2017 Apr 17. pii: canres.3044.2016.
    PubMed     Text format     Abstract available



  4. Correction: EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells.
    Cancer Res. 2017;77:2175.
    PubMed     Text format    


  5. WANG L, Shi C, Wright FA, Guo D, et al
    Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment.
    Cancer Res. 2017 Apr 10. pii: canres.3119.2016.
    PubMed     Text format     Abstract available


  6. OSE J, Poole EM, Schock H, Lehtinen M, et al
    Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium.
    Cancer Res. 2017 Apr 5. pii: canres.3322.2016.
    PubMed     Text format     Abstract available


    March 2017
  7. JOSEPHS DH, Bax HJ, Dodev T, Georgouli M, et al
    Anti-Folate Receptor-alpha IgE but not IgG Recruits Macrophages to Attack Tumors via TNFalpha/MCP-1 Signaling.
    Cancer Res. 2017;77:1127-1141.
    PubMed     Text format     Abstract available


    February 2017
  8. CHEN MW, Yang ST, Chien MH, Hua KT, et al
    The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer.
    Cancer Res. 2017 Feb 16. pii: canres.1115.2016.
    PubMed     Text format     Abstract available


  9. SUNDARAM KM, Zhang Y, Mitra AK, Kouadio JK, et al
    Prolactin receptor-mediated internalization of imaging agents detects epithelial ovarian cancer with enhanced sensitivity and specificity.
    Cancer Res. 2017 Feb 15. pii: canres.1454.2016.
    PubMed     Text format     Abstract available


  10. JUNG M, Russell AJ, Liu B, George J, et al
    A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.
    Cancer Res. 2017;77:971-981.
    PubMed     Text format     Abstract available


    January 2017
  11. ZHAO L, Ji G, Le X, Wang C, et al
    Long non-coding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer.
    Cancer Res. 2017 Jan 13. pii: canres.1615.2016.
    PubMed     Text format     Abstract available


    November 2016
  12. BAI S, Ingram P, Chen YC, Deng N, et al
    EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells.
    Cancer Res. 2016;76:6396-6409.
    PubMed     Text format     Abstract available


  13. YOKOYAMA Y, Zhu H, Lee JH, Kossenkov AV, et al
    BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
    Cancer Res. 2016;76:6320-6330.
    PubMed     Text format     Abstract available


  14. IORIO MV, Croce CM
    Commentary on microRNA Fingerprint in Human Epithelial Ovarian Cancer.
    Cancer Res. 2016;76:6143-6145.
    PubMed     Text format    


    October 2016
  15. KANLIKILICER P, Saber M, Bayraktar R, Mitra R, et al
    Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells.
    Cancer Res. 2016 Oct 14. pii: canres.0714.2016.
    PubMed     Text format     Abstract available


    September 2016
  16. CLARK CA, Gupta H, Sareddy GR, Pandeswara S, et al
    Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis and autophagy in ovarian cancer and melanoma.
    Cancer Res. 2016 Sep 26. pii: canres.0258.2016.
    PubMed     Text format     Abstract available


  17. JUNG JG, Shih IM, Park JT, Gerry E, et al
    Ovarian cancer chemoresistance relies on the the stem cell reprogramming factor PBX1.
    Cancer Res. 2016 Sep 2. pii: canres.0980.2016.
    PubMed     Text format     Abstract available


    August 2016
  18. WALTON J, Blagih J, Ennis D, Leung E, et al
    CRISPR/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high grade serous carcinoma.
    Cancer Res. 2016 Aug 16. pii: canres.1272.2016.
    PubMed     Text format     Abstract available


    May 2016
  19. SCHULTZ MJ, Holdbrooks AT, Chakraborty A, Grizzle WE, et al
    The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype.
    Cancer Res. 2016 May 23. pii: canres.2834.2015.
    PubMed     Text format     Abstract available


  20. KIM SY, Ebbert K, Cordeiro MH, Romero MM, et al
    Constitutive activation of PI3K in oocytes induces ovarian granulosa cell tumors.
    Cancer Res. 2016 May 9. pii: canres.3358.2015.
    PubMed     Text format     Abstract available


    April 2016
  21. FEHRINGER G, Kraft P, Pharoah PD, Eeles RA, et al
    Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.
    Cancer Res. 2016 Apr 20. pii: canres.2980.2015.
    PubMed     Text format     Abstract available


    March 2016
  22. REN YA, Mullany LK, Liu Z, Herron AJ, et al
    Mutant p53 promotes epithelial ovarian cancer by regulating tumor differentiation, metastasis, and responsiveness to steroid hormones.
    Cancer Res. 2016 Mar 10. pii: canres.1046.2015.
    PubMed     Text format     Abstract available


    February 2016
  23. HUANG YH, Peng W, Furuuchi N, Gerhart JV, et al
    Delivery of therapeutics targeting the mRNA-binding protein HuR using 3DNA nanocarriers suppresses ovarian tumor growth.
    Cancer Res. 2016 Feb 26. pii: canres.2073.2015.
    PubMed     Text format     Abstract available


    January 2016
  24. POPOVA T, Manie E, Boeva V, Battistella A, et al
    Ovarian cancers harboring inactivating mutations in CDK12 display a distinct genomic instability pattern characterized by large tandem duplications.
    Cancer Res. 2016 Jan 19. pii: canres.2128.2015.
    PubMed     Text format     Abstract available


    December 2015
  25. KANIGEL WINNER K, Steinkamp MP, Lee RJ, Swat M, et al
    Spatial modeling of drug delivery routes for treatment of disseminated ovarian cancer.
    Cancer Res. 2015 Dec 30. pii: canres.1620.2015.
    PubMed     Text format     Abstract available


  26. HILVO M, de Santiago I, Gopalacharyulu P, Schmitt WD, et al
    Accumulated metabolites of hydroxybutyric acid serve as diagnostic and prognostic biomarkers of high-grade serous ovarian carcinomas.
    Cancer Res. 2015 Dec 18. pii: canres.2298.2015.
    PubMed     Text format     Abstract available


  27. ISHIGURO T, Sato A, Ohata H, Ikarashi Y, et al
    Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available


  28. PERETS R, Drapkin R
    It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  29. LIU Y, Metzinger MN, Lewellen KA, Cripps SN, et al
    Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available


  30. PENG J, Hamanishi J, Matsumura N, Abiko K, et al
    Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-kappaB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available


  31. KARYAMPUDI L, Lamichhane P, Krempski J, Kalli KR, et al
    PD-1 blunts the function of ovarian tumor-infiltrating dendritic cells by inactivating NF-KappaB.
    Cancer Res. 2015 Nov 13. pii: canres.0748.2015.
    PubMed     Text format     Abstract available


    October 2015
  32. MOUGHON D, He H, Schokrpur S, Jiang ZK, et al
    Macrophage Blockade Using CSF1R Inhibitors Reverses The Vascular Leakage Underlying Malignant Ascites In Late-Stage Epithelial Ovarian Cancer.
    Cancer Res. 2015 Oct 15. pii: canres.3373.2014.
    PubMed     Text format     Abstract available


    September 2015
  33. KUHNERT F, Chen G, Coetzee S, Thambi N, et al
    Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available


  34. TURCOTTE M, Spring K, Pommey S, Chouinard G, et al
    CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
    Cancer Res. 2015 Sep 11. pii: canres.3569.2014.
    PubMed     Text format     Abstract available


  35. HEMACHANDRA LP, Shin DH, Dier U, Iuliano JN, et al
    Mitochondrial superoxide dismutase has a pro-tumorigenic role in ovarian clear cell carcinoma.
    Cancer Res. 2015 Sep 10. pii: canres.3799.2014.
    PubMed     Text format     Abstract available


    August 2015
  36. BAGLEY AF, Scherz-Shouval R, Galie PA, Zhang AQ, et al
    Endothelial Thermotolerance Impairs Nanoparticle Transport in Tumors.
    Cancer Res. 2015;75:3255-67.
    PubMed     Text format     Abstract available


  37. GOPINATHAN G, Milagre C, Pearce OM, Reynolds LE, et al
    Interleukin-6 Stimulates Defective Angiogenesis.
    Cancer Res. 2015;75:3098-107.
    PubMed     Text format     Abstract available


    July 2015
  38. BROWNE A, Tookman LA, Ingemarsdotter CK, Bouwman RD, et al
    Pharmacological Inhibition of beta3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity.
    Cancer Res. 2015;75:2811-21.
    PubMed     Text format     Abstract available


    June 2015
  39. CHEN P, Huhtinen K, Kaipio K, Mikkonen P, et al
    Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.
    Cancer Res. 2015 Jun 29. pii: canres.3242.2014.
    PubMed     Text format     Abstract available


    May 2015
  40. STEWART ML, Tamayo P, Wilson AJ, Wang S, et al
    KRAS genomic status predicts sensitivity to decitabine in an extended assay in ovarian cancer cell lines.
    Cancer Res. 2015 May 12. pii: canres.2860.2014.
    PubMed     Text format     Abstract available


    April 2015
  41. GAJADHAR AS, Johnson H, Slebos RJ, Shaddox K, et al
    Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity.
    Cancer Res. 2015;75:1495-503.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: